BioSpace News Archive

Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), today announced that its pending merger transaction with Qualigen, Inc. is currently expected to close after market hours today, Friday, May 22, 2020. As previously announced, Ritter’s stockholders voted to approve the proposals required to complete the merger transaction, including a reverse stock split within a range of 1-for-25 to 1-for-35, as d

AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR) today issued the following update: Despite the difficulties presented by the COVID-19 Pandemic, the Company continues to make progress on developing its proprietary Medical Robotic System. As AVRA CEO Barry Cohen explains, “The latest test results of AVRA’s Imaging and Detection System software designed to Detect, Identify, Diagnose, and Deliver an autonomous robotic surgical pr

Ra Medical Systems, Inc. (“Ra Medical”) (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases, today announced that it has closed the previously announced public offering of an aggregate of 22,222,222 shares of common stock (or common stock equivalents), together with accomp

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”) provides the following operational updates: Normal commercial operations will recommence from 1 June 2020 Confirmed that a prototype polygenic risk score can successfully discriminate between COVID-19 patients who required hospitalization from those who did not require hospitalization Continued discussions with third parties around use of existing CLIA and NATA accr

The U.S. Food and Drug Administration continued to take action in the ongoing response effort to the COVID-19 pandemic